December 19, 2014 10:23 AM ET


Company Overview of Shire Human Genetic Therapies Inc.

Company Overview

Shire Human Genetic Therapies Inc., a biopharmaceutical company, develops, and commercializes therapeutics for the treatment of genetic diseases caused by protein deficiencies. The company markets and sells Replagal, an enzyme replacement therapy for the long-term treatment of patients with Fabry disease, in 34 countries outside the United States. The company’s primary clinical programs include iduronate-2-sulfatase, an enzyme replacement therapy for the treatment of hunter syndrome, which is in phase III clinical trials; and Gene-Activated glucocerebrosidase, an enzyme replacement therapy for the treatment of Gaucher disease, which is in phase I/ II clinical trials. In addition, the company...

700 Main Street

Cambridge, MA 02139

United States

Founded in 1988

400 Employees





Key Executives for Shire Human Genetic Therapies Inc.

Age: 53
Advisor and Director
Age: 65
Senior Vice President of Manufacturing and Operations
Age: 71
Senior Vice President of Strategic Product Development
Age: 53
Senior Vice President of Human Resources and Corporate Services
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
TotipotentRx Corporation United States
Sequoia Pharmaceuticals, Inc. United States
Industry Dynamics Associates, Inc. United States
Schwarz Pharma Inc. United States
Symmetrix Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Shire Human Genetic Therapies Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at